CORALAB.BO

Healthcare Drug Manufacturers - Specialty & Generic

Coral Laboratories Limited

₹562.50
+10.50 +1.90% today

Price History

Not enough data

Key Stats

Market Cap
2.01B
Avg Volume
1,154
P/E (TTM)
10.46
EPS
₹53.76
52W High
₹679.00
52W Low
₹360.00
Div. Yield
0.0%

Valuation

Forward P/E
9.67
P/B Ratio
0.96
P/S Ratio
2.08
EV/EBITDA
5.43
EV/Revenue
1.03

Margins

Gross Margin 58.2%
Operating Margin 16.3%
Net Margin 19.9%
EBITDA Margin 19.0%

Growth & Returns

Revenue Growth (YoY)
57.4%
Earnings Growth (YoY)
110.0%
Earnings Growth (QoQ)
110.1%

Liquidity & Leverage

Debt / Equity
0.02
Total Cash
1.02B
Total Debt
43.27M

About

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products. It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. Further, it offers pharmaceutical formulations, including tablets, capsules, ointments, syrups, and injectables. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

corallab.com